MBI Seminar – David Mangelsdorf, Ph.D.

March 30, 2017

4:00 pm / 5:00 pm

Venue

159 Boyer Hall

Molecular Biology Institute Seminar
?The Diverse Metabolic Actions of FGF21?
David Mangelsdorf, Ph.D., Investigator, Howard Hughes Medical Institute; Professor & Alfred G. Gilman Distinguished Chair in Pharmacology; Raymond & Ellen Willie Distinguished Chair in Molecular Neuropharmacology in Honor of Harold B. Crasilneck, Ph.D., Department of Pharmacology & Biochemistry, UT Southwestern Medical Center, Dallas, Texas
Host: Tom Vallim, Ph.D., tvallim@mednet.ucla.edu